46 results

A participant in the Novavax vaccine trial at Howard University in Washington. Photograph: Kenny Holston/The New York Times

US biotech company Novavax announced a 90.4 per cent efficacy rate for its Covid-19 vaccine, boosting hopes that a new vaccine could come on stream th(...)

Dr Nita Patel, director of antibody discovery and vaccine development, lifts a vaccine vial at Novavax’s  labs in Maryland. Photograph:  Andrew Caballero-Reynolds/AFP via Getty Images

Novavax’s Covid-19 vaccine was 90 per cent effective in its late stage trial in the US and Mexico and proved it can tackle the virus variants of conce(...)

GlaxoSmithKline chose to provide an adjuvant that boosts the effectiveness of many vaccines to several partners, rather than develop its own Covid-19 shot. Photograph: Oli Scarff/Getty

GlaxoSmithKline (GSK) is banking that it can come back from behind in the race for a Covid-19 vaccine and play an important role preparing for new pan(...)

Pharma stocks slipped on Wall Street after US president Joe Biden backed intellectual property waivers for vaccines. Photograph: Angela Weiss / AFP

The major European indices closed slightly higher on Thursday, as Belgian brewing giant AB Inbev and several euro zone banks reported strong earnings,(...)

Novavax has told the EU it plans to begin delivering its Covid-19 vaccine to the bloc towards the end of this year.

Novavax has told the EU it plans to begin delivering its Covid-19 vaccine to the bloc towards the end of this year, new guidance that could lead to a (...)

There are currently four Covid-19 vaccines – Pfizer, Moderna, AstraZeneca and Johnson&Johnson – available for use in Ireland

Four Covid-19 vaccines – those from Pfizer, Moderna, AstraZeneca and Johnson & Johnson – are currently available for use in Ireland, followin(...)

Who wants to mix vaccines and could it bring advantages to inoculation programmes?

Oxford scientists are expanding efforts to test whether two different Covid-19 vaccines can be combined, after some European countries worried by rare(...)

A quality check being done on coronavirus vaccines at the Serum Institute of India  in Pune, India, in January. Photograph: Atul Loke/The New York Times

India, one of the world’s biggest vaccine producers, has imposed a de facto ban on jab exports as it seeks to prioritise local vaccinations amid an ac(...)

The study in the UK enrolled more than 15,000 participants aged between 18 and 84, including 27 per cent over the age of 65. Photograph: AFP via Getty

A coronavirus vaccine the EU is hoping to buy is 86 per cent effective against the so-called Kent variant, the company behind the jab has announced. (...)

When people were given a half dose of the AstraZeneca vaccine followed by a full dose at least a month later its efficacy rose to 90%. File photograph: Getty

The AstraZeneca Covid-19 vaccine developed with scientists at Oxford University continues to be in the news for all the wrong reasons. From being in(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »